Physician profile
Daniel Salama
NPI 1003861964
$5,009.50
in general payments reported to CMS, 2019-2025
18 companies · $3,284 in 2025
The $3,284 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2022: $221 · 2023: $726 · 2024: $541 · 2025: $3,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075 · Travel and Lodging: $1,797 · Education: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,075.26 |
| Travel and Lodging | $1,797.29 |
| Education | $678.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ets Wound Care LLC | $2,778.86 | 2025 | Mirragen Advanced Wound Matrix |
| Treace Medical Concepts, INC. | $313.39 | 2025 | |
| Aroa Biosurgery Incorporated | $284.34 | 2022-2024 | |
| Inari Medical, INC. | $234.44 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $213.77 | 2019-2024 | Augment Injectable, Anchorage |
| Integra Lifesciences Corporation | $166.56 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Avita Medical Americas, LLC | $145.61 | 2024 | |
| Biocomposites INC | $143.13 | 2023 | Stimulan |
| Fusion Orthopedics USA, LLC | $116.42 | 2025 | |
| Organogenesis INC. | $109.43 | 2023 | Puraply |
| Paragon 28, INC. | $87.97 | 2019 | |
| Medline Industries Lp | $87.62 | 2022 | |
| Solventum Corporation | $85.90 | 2024 | V.A.C.Instill, Activ.A.C. |
| Misonix INC | $79.35 | 2019 | |
| Kci USA, INC. | $74.91 | 2023 | Promogran Prisma, Activ.A.C., V.A.C.Instill |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $54.58 | 2025 | Collagenase Santyl, Pico 7 |
| Abbott Laboratories | $20.56 | 2025 | Proclaim |
| Merck Sharp & Dohme LLC | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Salama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.